← Evidence map

ReviewCurrent diabetes reviews2026

The Beneficial Effects of Combination Therapy With SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus.

Aimilianos Kalogeris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

The Beneficial Effects of Combination Therapy With SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus. | OpenQuestion